key: cord-0760756-rjjas8cx
authors: Bachani, Sumitra; Arora, Renu; Dabral, Anjali; Marwah, Sheeba; Anand, Pratima; Reddy, K Sravani; Gupta, Nitesh; Singh, Balwinder
title: Clinical Profile,Viral load(E,RdRP,ORF1 gene), Fetomaternal outcomes of pregnant women with COVID-19 in a Tertiary care Hospital of India : First 4 weeks experience: retrospective, single-centre descriptive study
date: 2020-10-28
journal: J Obstet Gynaecol Can
DOI: 10.1016/j.jogc.2020.09.021
sha: 59ecae343674e5ff1e12202fb6a912ea19760574
doc_id: 760756
cord_uid: rjjas8cx

Introduction The COVID19 pandemic raises a major concern about its severity in pregnancy, fetomaternal outcomes and risk of vertical transmission.The Cycle threshold indicating the viral load can be a contributory factor towards modifying the management of such pregnant women. We report a retrospective descriptive study regarding the clinical course, fetomaternal outcomes of pregnant women with COVID19. Methodology This is a single-center, retrospective study performed in a tertiary care hospital for pregnant women with COVID-19 in India. The medical records of the all women who delivered in the Covid facility from May 5th 2020 to June 5th 2020 were reviewed independently. Data extracted from the records included demography, obstetric details, co morbidities, disease severity, investigations, management and information on neonates (birthweight, Apgar score, and perinatal complications).Statistical analysis was performed by the SPSS program for Windows, version 17.0(SPSS, Chicago, Illinois) Results Amongst 348 women(suspects) tested for SARS-CoV-2, 57 women ( 57/348,16.3%) were confirmed positive based on qRT-PCR of nasopharyngeal specimen. Most women (45 /78.9 %) had mild infection with favourable fetomaternal outcomes. Three maternal mortalities were associated with co morbidities. Five neonates tested positive for SARS-CoV-2, remained haemodynamically stable and were subsequently discharged. Conclusions Majority of pregnant women with Covid-19 had mild disease and recovered subsequently with good perinatal outcomes. Women with co morbidities may have increased risk of severe morbidity and mortality.The Cycle threshold signifying the viral load and degree of infectivity can modify the management during pregnancy.Long-term outcomes and the potential mother-to-child vertical/horizontal transmission needs further study.

Introduction: The coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) first reported in Wuhan, China infects the host cells through angiotensin converting enzyme 2 (ACE2) receptors present predominantly within type II alveolar cells of the lung and across the aero-digestive tract. 1, 2 Most infections are mild or asymptomatic(80%); 15% severe cases need supplemental oxygen; while 5% are critical, requiring mechanical ventilation. 3 The first case was documented in Delhi,India on 30th January 2020. At the time of writing this article India has 440,215 cases,248,189 recoveries and 19,011 deaths in the country .4 Physiologic changes in the immune and cardiopulmonary systems render pregnant women more susceptible to respiratory pathogens. 5 However pregnant women seemingly have experienced fewer adverse events than were reported for SARS(Severe acute respiratory syndrome) and MERS(Middle East respiratory syndrome). 6 As the pandemic unfolds, prevention and control of infection amongst pregnant women and the potential risk of vertical transmission have become a major concern. The first study describing the clinical characteristics and investigating the possibility of vertical transmission of SARS-CoV-2 in nine pregnant women with laboratory-confirmed COVID-19, demonstrated that the severity in pregnant women was similar to that in non-pregnant adults and there was no evidence of vertical transmission as SARS-CoV-2 was not detected in amniotic-fluid, cord-blood and neonatal throat swab samples in six cases .7 Most recently, two neonates from mothers with COVID 19 are said to have tested positive for SARS-CoV-2 shortly following delivery, raising concerns about the possibility of vertical transmission. 8, 9 Increasing number of cases and shortage of hospital beds necessitates the concept of Cycle threshold(Ct) indicating the viral load. Progressive decrease of viral load was observed in all studies conducted on persons with Covid-19 however it was detectable till 17-21 days after onset of symptoms.. 10, 11 To substantiate the sparse research on pregnancy with COVID-19 from developing nations we report a retrospective descriptive study regarding the clinical course,Ct values, fetomaternal outcomes of pregnant women with Covid 19.

Study design and participants : A single-center, retrospective study performed in a medical college affiliated tertiary care hospital in the epicenter of this outbreak in India. Annual delivery rate is approximately 23000 with level III ICU(Intensive care unit). The medical records of all women who delivered in the Covid facility from May 5th 2020 to June 5th 2020 were reviewed independently by two authors. A laboratory confirmed case of COVID-19 was defined as a positive result on quantitative reverse-transcriptasepolymerase-chain-reaction (qRT-PCR) assay of Naso-pharyngeal swab specimens for adults and neonates.The kit for qRTPCR was designed by National Institute of Virology Pune (India) conforming to the national guidelines by ICMR(Indian Council of Medical Research) named LabGun TM COVID-19 RT-PCR kit, which ran primer probes through initial screening for E (envelope) gene specific to Sarbeco subgenus. Screen positive samples were confirmed positive if either of the two SARS-CoV-2 specific gene vide RDRp (RNA dependent RNA polymerase) gene or ORF-1bnsp14b gene was detected.. 12 Data extracted from the patient records included demographics, comorbidities, symptomatology, pregnancy outcomes and information on neonates (including birthweight, apgar score, and perinatal complications).Also noted were the laboratory tests,Ct values, drug therapy and length of hospital stay (LOS). Maternal deaths amongst this cohort were scrutinised. The study was approved by Institutional ethics committee.. Outcomes and definitions : 1.Demographic profile of the pregnant women. Clusters where SARS-CoV-2 affected more than four households were designated to be Containment area by the Government authorities. Testing Criteria: as per ICMR guidelines only symptomatic women, high risk contacts of confirmed cases and pregnant women from containment areas were tested for SARS-CoV-2 infection. 2. Discharge criteria: Women who were asymptomatic for 10 days post diagnosis including three days post resolution of symptoms were discharged. Repeat testing was not done considering the benefits of early discharge which was consistent with current operational guidelines for COVID 19 management with home isolation advisory. 3.Cycle threshold(Ct ).Cycle threshold was the number of cycles which had to be run on the PCR machine to detect the gene.Threshold value for infectivity was taken as 35 cycles or below for E,RDRp and ORF gene.Thus a higher Ct value was suggestive of a lower viral load. The severity of disease was classified as mild, moderate ,severe or critical as per the WHO country and technical guidance. 3 4.Maternal mortality:Maternal deaths occurring during pregnancy or within 6 weeks of abortion/delivery. Statistical Analysis: Statistical analysis was performed by the SPSS program for Windows, version 17.0(SPSS, Chicago, Illinois). Continuous variables are presented as mean ± SD, and categorical variables are presented as absolute numbers and percentage. Data were checked for normality before statistical analysis. Normally distributed continuous variables were compared using the unpaired t test, whereas the Mann-Whitney U test was used for those variables that were not normally distributed. For all statistical tests, a p value less than 0.05 was taken to indicate a significant difference.

Patient Characteristics: Total 1625 deliveries were noted during the study period. Amongst them 348 women were tested for SARS-CoV-2 and 57 women ( 57/348,16.3%) were confirmed positive and their data was analysed. Amongst these 15(26.3%) were residents of Containment zones. The mean ± SD age of cohort was 26.71 ± 4.54 years.Most women (45 /78.9 %) had mild infection with one or two spikes of low grade fever, cough and/or diarrhoea which resolved in two to three days.Three( 5.2 %) women had moderate( fever and breathlessness) symptoms. Amongst women with spontaneous onset of labour, 13(22.8%) experienced preterm delivery. (Table 1 ).Common comorbidities were anaemia ,hypertensive disorders of pregnancy and thrombocytopenia. (Fig 1) . Five(8.7%) women were admitted in ICU amongst whom two recovered. Investigations; The haematological profile was within normal range. (Table 2 ) The mean Ct value was 31.45 in asymptomatic women, 25.84 in women with fever, 28.91 each in women with diarrhoea and or respiratory distress.The association between clinical symptoms and cycle threshold values(p=0.086) was not statistically significant ( Table 2) . Pregnancy outcomes Labour was spontaneous in 21(36.8%) women and induced in 10 (17.5%) with prostaglandins for obstetric indications. Elective cesarean section was performed in 09(15.5% )while 17(29.3% ) underwent emergency caesarean section for various fetomaternal indications commonest being fetal distress. (Figure 2 ).Covid positive status did not influence the mode of termination. Average Length of stay (LOS) in hospital was 10-12 days. Only one woman who developed deep vein thrombosis and wound infection was discharged after four weeks. Maternal Mortality: Three maternal mortalities (5.2%) were individually analysed. (Table 3) Patient 1: Primigravida, 26 years, term pregnancy reported in labour with moderate symptoms of COVID 19 confirmed by qRT-PCR.She had hypothyroidism, moderate anaemia and thrombocyto-penia. Ct values indicated moderate viral load. She was transfused necessary blood products and underwent emergency cesarean section for fetal distress. Postoperative day(POD) one she developed a disoriented, agitated and confused state, refusing to feed her baby. She was put on non invasive ventilation(FiO2 0.5) in ICU, administered 3rd generation antibiotics(Piperacilin, Clindamycin, Azithromycin) and prophylactic Low molecular weight heparin (LMWH). However she had a sudden death on POD3 preceded by severe breathlessness and cardiac arrest. Cause of death was Pulmonary embolism( Complication of COVID19). Patient 2: G3P2L2, 32 years, previous two cesarean deliveries, at 32 +5 weeks gestation with severe fetal growth restriction, chronic hypertension, medical renal disease(MRD) stage 4, hypothyroidism and deranged liver enzymes. She was asymptomatic, diagnosed positive for SARS-CoV-2 on testing as she resided in a containment zone. Ct values were in non infective category, renal and liver function was deranged ,chest X Ray was normal. However due to deteriorating renal function, post haemodialysis she underwent cesarean section on day10 of diagnosis under subarachnoid block. She was administered renal disease modifying drugs, antibiotic Piperacilin and monitored for fluid balance.She developed severe metabolic /lactic acidosis on POD1.Despite fluid and electrolyte corrections, mechanical ventilation she had cardiac arrest and expired (day11 of COVID positive status).Cause of death was severe metabolic acidosis due acute on chronic renal failure.(COVID 19 related death) Patient 3: P3L3,25 years (5 weeks post partum) underwent subtotal hysterectomy for Gestational trophoblastic disease at peripheral district hospital and was referred on POD1 as surgery was complicated by severe haemorrhage. She was febrile and tested positive for SARS-CoV-2 on day of admission.The Ct values were just above the cut-off. She underwent single cycle chemotherapy( Methotrexate) and uterine artery embolisation. Multiple haemotransfusions were given and she remained on ventilatory support and vasopressors in the post op period with Fio2 of 0.7 and PEEP of 6. She was administered 3rd/4th generation antibiotics(Meropenum, Clindamycin, Azithromycin, Metrogyl) and prophylactic LMWH.Her total leucocyte count was18,200 /mm 3 and serum creatnin was1.5 mg/L.,Chest X Ray had bilateral basal infiltrates. She developed severe hypoxia, hypotension on POD 7 (day 08 of Covid positive status) followed by cardiac arrest and expired. Cause of death was Acute respiratory distress and septic shock(complication of COVID 19).

Neonatal Outcomes: Mean gestation ( ±SD) and birth weight( ± SD) was 36.72 ± 2.15 weeks and 2910 ± 663.12 grams respectively. Approximately one fourth cohort was born preterm (13/56, 22.8 %); 41% were females.Amongst 56 neonates tested, five (8.9%) were confirmed positive for SARS-CoV-2.One neonate was symptomatic and received respiratory support for 48 hours while four were asymptomatic. (Table 4 ). Two neonates(3.4%) were detected positive for SARS-CoV-2 within 24 hours of birth. In all, three neonates had been separated from mother, and still tested positive. (Table 5). Hence, in total 4 neonates amongst the five tested positive (80%) were either separated at birth or tested within first 24 hours of birth. Viral load as assessed by cycle threshold (Ct) of qRTPCR was highest for neonate 3 and neonate 4 (Ct 15.82 & 15.33) whereas neonate positive on day 14 had Ct above detection level (36.37). All five neonates remained haemodynamically stable during hospital stay and were subsequently discharged. One neonate,s mother ( Patient 1) lost her life to COVID 19.

Current study summarises the maternal and neonatal profiles in 56 mother and baby dyad and one postpartum woman. Majority of the women were from the non-containment zone who reported undetected due to ICMR guideline of 'no universal testing' in general population.The mean maternal age(26 years) was lesser than other reported studies as 36 years by Smith et al and 29.7 years by Breslin et al 12, 13 possibly because India has a large youth population. In current study 38.8% inclusive of all preterm deliveries presented in spontaneous labour,17.8 % were induced hence vaginal delivery rates (45.6 %) were marginally higher than cesarean section. A systematic review of 33 studies described the outcomes of 385 pregnant women with COVID-19 with gestational age at birth ranging from 30 to 41 weeks and a preterm birth rate of 15.2%. 14 While many of the preterm deliveries were iatrogenic(maternal indications and fetal distress) in some, in others indication is not clear. 14 . Majority of cesareans in current study were performed for fetal distress (42.5%) which was similar to other studies .7,15,16 Could this suggest an underlying pathology of placental insufficiency/ hypoxia leading to fetal distress in Covid 19 infection.

The commonest presenting symptom in current study was low grade fever in 78.9 % women which was similar to other studies. 1, 5, 17, 16 Asymptomatic women(10/57,17.4%) were incidentally detected as they resided in containment zone. Three women (5.2%) had moderate infection one of whom progressed to severe category and expired. Early reports suggest that the percentages in the pregnant population are similar to those described for non pregnant adults with COVID-19 infections (approximately 80% mild, 15% severe and 5% critical disease). 12 Other symptoms, including nasal congestion, rash, sputum production, headache, malaise and loss of appetite were reported in less than 5% of cases 14 It has been suggested that the limited data currently available does not indicate that pregnant individuals are at an increased risk of infection, severe morbidity or mortality compared with non pregnant individuals in the general population. 18 In current cohort five women (8.7 %) who were admitted in ICU had comorbidities as moderate anaemia, severe thrombocytopenia, chronic hypertension with medical renal disease, and malignancy. Whether COVID19 increases the risk of severe morbidity and mortality in high risk pregnancies is a question to be answered. A review of 108 pregnancies did not report any maternal deaths. 17 However Breslin et al 13 have reported severe morbidity in mothers with high BMI and complicated medical history with COVID19. Hantouchzadeh S et al 19 reported case series of nine pregnant women diagnosed with severe COVID-19 disease in their second or third trimester. They reported seven deaths, one remained critically ill and ventilator dependent and one recovered after prolonged hospitalisation. Five amongst the women who died were more than 35 years of age older than current study population. Most of their women 19 had comorbidities as obesity, gestational diabetes, hypothyroidism and all deaths were due to severe COVID19.They also reported that the maternal outcomes were more severe compared with outcomes of other high and low risk familial/household members of these women. 19 Association with comorbidities definelty worsens the pregnancy outcome in women with Covid 19.

La Scola et al have reported a strong correlation between Ct value and sample infectivity in a cell culture model in 183 samples.They concluded that patients with Ct values equal or above 34 do not excrete infectious viral particles . 10 In current study, cycle threshold value of < 35 was interpreted as positive for SARS-CoV-2 RNA.However no significant association was found between clinical symptoms and cycle threshold values(P=0.08) .This was likely because the majority of the patients had mild symptoms only.Wang et al reported mean Ct values specimen for different body compartments to be more than 30, except for nasal swabs which was a mean of 24.3 indicating high viral load in these specimens. 20 In current study none of the SARS-CoV-2 positive neonates developed severe manifestations of the disease(one neonate lost its mother to COVID 19) and were subsequently discharged.This suggests a good neonatal outcome in pregnant women with SARS-CoV-2 infection. Zaigham et al 17 reported one positive neonate amongst 75 tested for SARS-CoV-2 who was clinically well but had transient lymphocytopenia and deranged liver function. Fan et al 21 reported two neonates with mild lymphocytopenia and radiological findings of pneumonia, although both were clinically well and recovered fully.Thus we cannot exclude that the fetus and newborn baby might show a response, often subclinical, to the maternal infection, hence vertical maternal-fetal transmission cannot be ruled out.This view has been seconded by a recently published study 22 which reported three infants born by cesarean section who tested positive for SARS-CoV-2 two days after birth. However, Schwartz et al 23 in their analysis of 38 infected pregnancies did not find any evidence for intrauterine trans-mission.Also neonates can definitely acquire SARS-CoV-2 in the post-partum period (horizontal transmission), similar to adults. The positive neonate 3 who tested beyond 48 hours once mother was confirmed, points towards this route of transmission.The viral load of three neonates in present study was comparable with the Ct reported from adults, thus raising the possibility that despite similar viral load as adults, manifestations are milder in neonates. 24 Strength of study: Single centre descriptive study with no selection bias. RTPCR was used for confirming positives which is the gold standard. Study substantiates observations of Cycle threshold for specific SARS-CoV-2 viral load which makes it more robust. Same diagnostic criteria has been used for the neonates. It can contribute important new information regarding the viral load and infectivity of the case. It adds to the sparse data presently available regarding Covid 19 in pregnancy from developing countries. Limitations: Retrospective study hence we could not get additional haematological and radiological data to correlate with severity of infection.We were unable to test samples of the placenta, amniotic fluid, and neonatal blood for antibodies for evidence of vertical transmission.

Majority of pregnant women with Covid-19 had mild disease and recovered subsequently with good perinatal outcomes.Pregnant women with co morbidities and COVID19 may have increased risk of severe morbidity and mortality. Fetal distress which was the commonest indicator for cesarean delivery, raises a research arena of placental insufficiency in pregnancy with COVID 19. The Cycle threshold for SARS-CoV-2 virus signifies the viral load and can be used to determine the degree of infectivity.The maternal, fetal and neonatal outcomes of those pregnant women infected in late pregnancy were achieved with intensive, active management which might be the best practice in absence of more accurate data. Long-term outcome and the potential mother-to-child vertical/horizontal transmission needs further research. 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Country & technical guidance -coronavirus disease (COVID-19) [website]. Geneva: World Health Organization

Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases

What are the risks of COVID 19 infection in pregnant women

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Newborn baby tests positive for coronavirus in London

Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

Evaluation of RdRp& ORF-1b-nsp14-based realtime RT-PCR assays for confirmation of SARS-CoV-2 infection: An observational study

Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review

COVID-19 in pregnancy: early lessons

A systematic scoping review of COVID-19 during pregnancy and childbirth

Clinical and CT Imaging Features of the COVID-19 Pneumonia: Focus on Pregnant Women and Children

Analysis of pregnancy outcomes of pregnant women during the epidemic of new coronavirus pneumonia in Hubei

Maternal and Perinatal Outcomes with COVID-19: a systematic review of 108 pregnancies

Clinical update on COVID -19 in pregnancy: A review article

Maternal death due to COVID-19

Detection of SARS-CoV-2 in different types of clinical specimens

Perinatal Transmission of COVID-19 Associated SARS-CoV-2 : Should We Worry?

Neonatal Early-Onset Infection With SARS-CoV-2 in 33

Neonates Born to Mothers With COVID-19 in Wuhan, China

An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes

Clinical features and dynamics of viral load in imported and nonimported patients with COVID-19